The Globus family of brands (GFOB) announced the appointment of Chris Hall as its new managing director in the Asia Pacific.

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst ...

Globus expects the deal to close in the backend of Q2 2025. Globus CEO Dan Scavilla said the move enables the company to “expand into new markets for future growth, while gaining access to world ...

Globus Medical, Inc. reported $657,293 million in sales and $60,275 million in operating profit for the quarter ending December 31, 2024, which was above both Wall Street’s expectations and management ...

Stay up to date on the latest updates from Globus Medical, including progress on FDA clearance for their XR augmented reality headset.

CEO Daniel Scavilla highlighted record revenue ... acquisition of Nevro Corporation for $250 million, aimed at expanding Globus' reach into the $2 billion neuromodulation market.

said Dan Scavilla, President and CEO. “The potential for Globus has never been greater, as we continue to redefine spine surgery and address unmet clinical needs with procedural solutions built ...

Joining today's call from Globus Medical will be Dan Scavilla, President and CEO; and Keith Pfeil, Chief Operating and Chief Financial Officer. This review is being made available via webcast ...